Lv71
4558 积分 2022-08-01 加入
Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial
4天前
已完结
Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer
1个月前
已完结
An Updated Comprehensive Pharmacovigilance Study of Drug‐Induced Thrombocytopenia Based on FDA Adverse Event Reporting System Data
2个月前
已完结
EANM’24 Abstract Book Congress Oct 19-23, 2024
3个月前
已完结
Programmable DNA Circuit-Facilitated Determination of Circulating Extracellular Vesicle PD-L1 for Lung Cancer Diagnosis and Immunotherapy Response Prediction
4个月前
已完结
Review of Dose Justifications for Antibody-Drug Conjugate Approvals from Clinical Pharmacology Perspective: a Focus on Exposure-Response Analyses
4个月前
已完结
Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer
4个月前
已完结
Next-generation antibody-drug conjugates for breast cancer: Moving beyond HER2 and TROP2
5个月前
已完结
Antibody-Drug Conjugates in Breast Cancer: Toward a Molecular Perspective Into Clinical Practice
5个月前
已完结
First-in-human, phase 1 dose-escalation and dose-expansion study of a RET inhibitor SY-5007 in patients with advanced RET-altered solid tumors
5个月前
已关闭
皖公网安备34019202002308
